戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ole for secretory SMCs in the development of atheromatous plaque.
2 m (Lu-Tex) is a photosensitizer that targets atheromatous plaque.
3 ET-1 and its precursor, big ET-1, within the atheromatous plaque.
4 racterized by the presence of lesions called atheromatous plaques.
5 as reference segments and 1318 segments with atheromatous plaques.
6 , a pathogen also linked to endocarditis and atheromatous plaques.
7 mutans has been found with high frequency in atheromatous plaques.
8 abetes, aortic dimension, the presence of an atheromatous plaque and smoke in the left atrium.
9  overexpression of collagenolytic enzymes in atheromatous plaques and implicated MMPs in the destabil
10 e-related increase in the incidence of aorta atheromatous plaques and periaortic vascular channels in
11 ynthesis may influence both the stability of atheromatous plaques and the development of restenotic l
12 ent reductions in the inflammatory status of atheromatous plaque, and suggest that this effect may ha
13 ies have been detected in circulation and in atheromatous plaques, and immune complexes (ICs) formed
14 PA and vWF may correlate with instability of atheromatous plaques, and that their decrease after coro
15 s plaques < or = abdominal aortic aneurysm < atheromatous plaques; and correlate with macrophage cont
16 ity lipoprotein (OxHDL) within the intima of atheromatous plaques as well as in plasma; however, its
17                                In our study, atheromatous plaques (ATH) and macroscopically intact ti
18           Pathological changes consisting of atheromatous plaques, atherosclerotic microaneurysms ext
19              We found that both the coronary atheromatous plaque burden and smoking habit are associa
20 que in the coronary arteries is a marker for atheromatous-plaque burden and is predictive of future r
21                                  Fibrous and atheromatous plaques but not normal arteries contained N
22 nical events but may evolve into complicated atheromatous plaques characterized by an accumulation of
23                                     Finally, atheromatous plaques contained higher levels of proinfla
24                               The core of an atheromatous plaque contains lipids, macrophages, and ce
25 hought to play an important role in coronary atheromatous plaque destabilization.
26                                              Atheromatous plaque disruption often presents as complex
27 s have been developed that ablate or section atheromatous plaque during percutaneous coronary interve
28 h, composition, and rupture of intracoronary atheromatous plaque-factors that define the natural hist
29          Metformin attenuated Ang-II-induced atheromatous plaque formation and aortic aneurysm in Apo
30  regressing angiotensin II (Ang-II)-mediated atheromatous plaque formation in ApoE(-/-) mice.
31 have demonstrated a high incidence of CMV in atheromatous plaques from the coronary circulation.
32 sease, but the paucity of neutrophils in the atheromatous plaque has led to neglect of its potential
33     Improved understanding of the biology of atheromatous plaques has led to the concept of plaque vu
34 ynamic therapy (PDT) agent that localizes in atheromatous plaque in which it can be activated by far-
35  associated with irregularity and rupture of atheromatous plaques in both the carotid and coronary ar
36 al microbiota to the bloodstream and then to atheromatous plaques in carotid or other peripheral arte
37 t C pneumoniae can frequently be detected in atheromatous plaques in coronary arteries.
38 tic and asymptomatic patients would identify atheromatous plaques independently of stenosis.
39  showed that the enhanced glycolytic flux in atheromatous plaques of ApoE(-/-) mice was associated wi
40 lut1 connects the enhanced glucose uptake in atheromatous plaques of ApoE(-/-) mice with their myelop
41 o cause clinical manifestations (vulnerable, atheromatous plaques) or those less frequently associate
42 therosclerotic lesions (P < 0.004) and fewer atheromatous plaques (P < 0.008) when compared with ApoE
43                 Histological analysis of the atheromatous plaques showed no difference between lesion
44 al for atraumatic and effective debulking of atheromatous plaque through a biological mechanism, the
45 play a significant role in atherogenesis and atheromatous plaque vulnerability and may determine rapi
46 abounded in the macrophage-rich shoulders of atheromatous plaques with histological features of vulne

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。